To characterize the effect of white matter microstructural integrity on cerebral tissue and long-term functional outcomes after acute ischemic stroke (AIS).
Consecutive AIS patients with brain MRI acquired within 48 hours of symptom onset and 90-day modified Rankin Scale (mRS) score were included. Acute infarct volume on diffusion-weighted imaging (DWIv) and white matter hyperintensity volume (WMHv) on T2 fluid-attenuated inversion recovery MRI were measured. Median fractional anisotropy (FA), mean diffusivity, radial diffusivity, and axial diffusivity values were calculated within normal-appearing white matter (NAWM) in the hemisphere contralateral to the acute lesion. Regression models were used to assess the association between diffusivity metrics and acute cerebral tissue and long-term functional outcomes in AIS. Level of significance was set at p < 0.05 for all analyses.
Among 305 AIS patients with DWIv and mRS score, mean age was 64.4 ± 15.9 years, and 183 participants (60%) were male. Median NIH Stroke Scale (NIHSS) score was 3 (interquartile range [IQR] 1–8), and median normalized WMHv was 6.19 cm 3 (IQR 3.0–12.6 cm 3). Admission stroke severity (β = 0.16, p < 0.0001) and small vessel stroke subtype (β = −1.53, p < 0.0001), but not diffusivity metrics, were independently associated with DWIv. However, median FA in contralesional NAWM was independently associated with mRS score (β = −9.74, p = 0.02), along with age, female sex, NIHSS score, and DWIv.
(1) The 1st Affiliated Hospital of Zhengzhou University, travel reimbursement for lecture(2) RSNA, travel reimbursement for QIBA meeting
(1) Patent on ?Delay-compensated calculation of tissue blood flow,? US Patent 7,512,435.(2) Patent on
(1) NIH/NINDS, P50 NS051343, Principal Investigator, 2011-2016 (2) NIH/NINDS, U01NS086625-01, Investigator, 2014-2017 (3) NIH/NINDS, R01NS082285, Investigator, 2013-2017 (4) NIH/NINDS, R01 NS083654-01, Investigator, 2016-2017 (5) NIH/NINDS, R01NS086905-01A1, Investigator, 2016-2017 (6) NBIB, HHSN268201500021C, Principal Investigator, 2015-2017
(1) Co-inventor of a patent on ?Delay-compensated calculation of tissue blood flow,? US Patent 7,512,435. March 31, 2009, and the patent has been licensed to General Electric, Siemens, Imaging Biometrics and Olea Medical.
(1) Co-inventor of a patent on ?Delay-compensated calculation of tissue blood flow,? US Patent 7,512,435. March 31, 2009, and the patent has been licensed to General Electric, Siemens, Imaging Biometrics and Olea Medical.
(1) Genzyme Co., (2) Merck, (3) Boston Biomedical Associates, (4) Omniox, (5) BioTelemetry
(1) Stroke, Assistant Editor, 2010 - (2) Current Treatment Options in Cardiovascular Medicine, Section Editor, 2014 -
NIH/NINDS R01NS082285 (PI), 2013 -current NIH/NINDS R01NS086905 (PI), 2015 - current
Go to Neurology.org for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.